Assignee
AMRYT ENDO INC
US·10 granted patents·16 pending applications·48 citations·filing 2020–2025
Top patents by PatentIndex Score
26 records- 0198US11510963B1Method of treating diseasesAMRYT ENDO INC·Filed 2022·Granted Nov 29, 2022·9 cites·25 claims
- 0297US11857595B2Method of treating diseasesAMRYT ENDO INC·Filed 2022·Granted Jan 2, 2024·5 cites·25 claims
- 0397US11338011B2Method of treating diseasesAMRYT ENDO INC·Filed 2020·Granted May 24, 2022·10 cites·21 claims
- 0496US11986529B2Pharmaceutical compositions and related methods of deliveryAMRYT ENDO INC·Filed 2022·Granted May 21, 2024·3 cites·18 claims
- 0596US11400159B2Pharmaceutical compositions and related methods of deliveryAMRYT ENDO INC·Filed 2020·Granted Aug 2, 2022·7 cites·9 claims
- 0695US12251418B2Method of treating diseasesAMRYT ENDO INC·Filed 2024·Granted Mar 18, 2025·1 cites·21 claims
- 0795US12246054B2Method of treating diseasesAMRYT ENDO INC·Filed 2024·Granted Mar 11, 2025·1 cites·17 claims
- 0895US11969471B2Pharmaceutical compositions and related methods of deliveryAMRYT ENDO INC·Filed 2022·Granted Apr 30, 2024·2 cites·18 claims
- 0991US11141457B1Oral octreotide therapy and contraceptive methodsAMRYT ENDO INC·Filed 2020·Granted Oct 12, 2021·7 cites·12 claims
- 1090US11890316B2Oral octreotide therapy and contraceptive methodsAMRYT ENDO INC·Filed 2021·Granted Feb 6, 2024·3 cites·26 claims
- 1188US2024082343A1Method of treating diseasesAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1284US2025170204A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 1383US2024041973A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1483US2025339499A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 1581US2023201302A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1679US2024016899A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1778US2022339240A1Oral octreotide administered in combination with other therapeutic agentsAMRYT ENDO INC·Filed 2022·Application pending·0 cites
- 1877US2023173034A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 1977US2025000933A1Terlipressin compositions and their methods of useAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 2076US2025345438A1Pharmaceutical compositions and related methods of deliveryAMRYT ENDO INC·Filed 2025·Application pending·0 cites
- 2174US2024123024A1Oral octreotide therapy and contraceptive methodsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 2268US2022313773A1Terlipressin compositions and their methods of useAMRYT ENDO INC·Filed 2021·Application pending·0 cites
- 2368US2024050533A1Oral octreotide therapy in combination with digoxin or lisinoprilAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 2459US2025152674A1Oral octreotide for treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 2558US2022202911A1Oral octreotide therapy in combination with digoxin or lisinoprilAMRYT ENDO INC·Filed 2020·Application pending·0 cites
- 2644US2026000620A1Oral dosage formsAMRYT ENDO INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AMRYT ENDO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →